SCIENTIFIC ADVISORY BOARD
Laura Finn, M.D.
Dr. Laura Finn specializes in hematology/oncology at Ochsner MD Anderson Cancer Center. She received her medical degree from Louisiana State University School of Medicine in New Orleans. She completed residency in internal medicine at Earl K. Long at LSU in Baton Rouge, Louisiana, where she was chief medical resident. Dr. Finn completed a hematology/oncology fellowship at Mayo Clinic School of Graduate Medical Education in Jacksonville, Florida where she was chief fellow and remained on faculty of hematology and stem cell transplant as an assistant professor of medicine and medical director of inpatient bone marrow transplant for two years. She completed advanced training in stem cell transplant as a Mayo Clinic Scholar at the University of Minnesota.
Dr. Finn is director of Ochsner Health’s Hematology and Stem Cell Transplant Program. She has interests in all blood disorders with a research focus in leukemia and myelodysplastic syndrome. She is the deputy director of hematology for the Precision Cancer Therapies Program. Dr. Finn is involved in medical resident and fellow education as program director of Ochsner’s Hematology/Oncology Fellowship Program. Dr. Finn is a member of the American Society of Hematology Committee on Government Affairs. Dr. Finn has a strong interest in promoting shared decision making and palliative medicine as part of her routine cancer care. She is also active in promoting health care policy changes for the fields of hematology, stem cell transplant, and cancer research through advocacy with the state and federal governments. She promotes federal support for cancer research funding and sickle cell disease policy recognition
Your Support Matters
Donate to CAGLA CARES and make a real, lasting difference in our state’s cancer care.
Watch Video at WWLTV.com
MAKE A DIFFERENCE
Each donation strengthens our efforts towards innovative legislation, advanced cancer research, and enhanced patient care. Back our cause, help us realize a cancer-free Louisiana.